(Q35732971)

10 August 2017

title

Cyclooxygenase 2-derived prostaglandin E2 regulates the angiogenic switch (English)

1 reference

10 August 2017

1 reference

Dingzhi Wang

1

1 reference

10 August 2017

Raymond N DuBois

series ordinal

2

1 reference

10 August 2017

language of work or name

English

0 references

publication date

5 January 2004

1 reference

Proceedings of the National Academy of Sciences of the United States of America

10 August 2017

published in

1 reference

10 August 2017

volume

101

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

415-416

1 reference

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

10 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Inhibitors of cyclo-oxygenase 2: a new class of anticancer agents?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Host prostaglandin E(2)-EP3 signaling regulates tumor-associated angiogenesis and tumor growth

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

COX-2: a target for colon cancer prevention

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Acceleration of intestinal polyposis through prostaglandin receptor EP2 in Apc(Delta 716) knockout mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Cyclooxygenase-2: a novel target for cancer chemotherapy?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Distribution and function of prostanoid receptors: studies from knockout mice

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Epidermal growth factor receptor tyrosine kinase inhibitors as potential cancer chemopreventives.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

27 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0307640100

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0307640100

Prostanoid receptors: subtypes and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0307640100

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0307640100

Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=327160

Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice

25 September 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0307640100

Combinatorial chemoprevention of intestinal neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0307640100

21 January 2018

Identifiers

DOI

10.1073/PNAS.0307640100

1 reference

release_npexcdmhgrd4tk26sm3qefi4c4

10 August 2017

0 references

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/npexcdmhgrd4tk26sm3qefi4c4

mapped directly with Wikidata item

24 November 2022

based on heuristic

PMC publication ID

327160

1 reference

10 August 2017

1 reference